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Abstract. 
 
CCS embryonic stem (ES) cells possessing 
 
two mutant alleles (
 
ry
 
1
 
r
 
2
 
/
 
ry
 
1
 
r
 
2
 
) for the skeletal muscle 
ryanodine receptor (RyR) have been produced and in-
jected subcutaneously into severely compromised im-
munodeficient mice to produce teratocarcinomas in 
which Ry
 
1
 
R expression is absent. Several primary fibro-
blast cell lines were isolated and subcloned from one of 
these tumors that contain the knockout mutation in 
both alleles and exhibit a doubling time of 18–24 h, are 
not contact growth inhibited, do not exhibit drastic 
morphological change upon serum reduction, and pos-
sess the normal complement of chromosomes. Four of 
these fibroblast clones were infected with a retrovirus 
containing the cDNA encoding myoD and a puromycin 
selection marker. Several (1–2 
 
m
 
g/ml) puromycin-resis-
tant subclones from each initial cell line were expanded 
and examined for their ability to express myoD and to 
form multinucleated myotubes that express desmin and 
myosin upon removal of mitogens. One of these clones 
(1B5 cells) was selected on this basis for further study. 
These cells, upon withdrawal of mitogens for 5–7 d, 
were shown by Western blot analysis to express key tri-
adic proteins, including skeletal triadin, calsequestrin, 
FK506-binding protein, 12 kD, sarco(endo)plasmic 
reticulum calcium–ATPase1, and dihydropyridine re-
ceptors. Neither RyR isoform protein, Ry
 
1
 
R (skeletal), 
Ry
 
2
 
R (cardiac), nor Ry
 
3
 
R (brain), were detected in dif-
ferentiated 1B5 cells. Measurements of intracellular 
Ca
 
2
 
1
 
 by ratio fluorescence imaging of fura-2–loaded 
cells revealed that differentiated 1B5 cells exhibited no 
responses to K
 
1
 
 (40 mM) depolarization, ryanodine 
(50–500 
 
m
 
M), or caffeine (20–100 mM). Transient 
transfection of the 1B5 cells with the full-length rabbit 
Ry
 
1
 
R cDNA restored the expected responses to K
 
1
 
 de-
polarization, caffeine, and ryanodine. Depolarization-
induced Ca
 
2
 
1
 
 release was independent of extracellular 
Ca
 
2
 
1
 
, consistent with skeletal-type excitation–contrac-
tion coupling. Wild-type Ry
 
1
 
R expressed in 1B5 cells 
were reconstituted into bilayer lipid membranes and 
found to be indistinguishable from channels reconsti-
tuted from rabbit sarcoplasmic reticulum with respect 
to unitary conductance, open dwell times, and re-
sponses to ryanodine and ruthenium red. The 1B5 cell 
line provides a powerful and easily managed homolo-
gous expression system in which to study how Ry
 
1
 
R 
structure relates to function.
 
E
 
lucidation
 
 of the molecular details of excitation–
 
contraction (e–c)
 
1
 
 coupling is a major area of
research in muscle biology. The process by which
depolarization of the sarcolemma causes the release of cal-
cium from the sarcoplasmic reticulum (SR) to initiate
crossbridge formation and, ultimately, muscle contraction
is defined as e–c coupling (36). The ryanodine receptor
(RyR) is the site of calcium release from SR in skeletal
and cardiac muscle (28). Studies that have addressed the
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1. 
 
Abbreviations used in this paper
 
: BLM, bilayer lipid membrane;
 
a
 
1-DHPR, 
 
a
 
-1 subunit of L-type voltage-dependent Ca
 
2
 
1
 
 channel dihy-
dropyridine receptor; e–c, excitation–contraction; ES, embryonic stem;
FKBP12, FK506 binding protein, 12 kD; G418, neomyocin antibiotic ana-
logue; HIHS, heat-inactivated horse serum; 
 
P
 
o
 
, open probability; Ry
 
1
 
R,
Ry
 
2
 
R, and Ry
 
3
 
R, skeletal isoform of ryanodine receptor, cardiac isoform
of ryanodine receptor, and brain isoform of ryanodine receptor; SCID, se-
verely compromised immunodeficient; SERCA, sarco(endo)plasmic retic-
ulum Ca
 
2
 
1
 
-ATPase; SR, sarcoplasmic reticulum.
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molecular details of how ryanodine receptor structure re-
lates to function have thus far been limited to heterolo-
gous expression systems that lack key accessory proteins
known to be essential for e–c coupling. the full-length
cDNA encoding for the skeletal isoform of ryanodine re-
ceptor (Ry
 
1
 
R) has been expressed in CHO cells (32), 
 
Xe-
nopus
 
 oocytes (31), COS-1 cells (9), and Sf9 insect cells (5).
Expression of the Ry
 
1
 
R cDNA in these cells has resulted
in channels whose properties are only similar to those of
native Ca
 
2
 
1
 
 channels isolated from skeletal SR. We believe
that this is because studies that use heterologous expres-
sion systems to reconstitute Ry
 
1
 
R function do so in cells
that do not express the other important proteins involved
in e–c coupling that are normally targeted to the skeletal
muscle triad and that have been shown to interact with
and modulate the function of Ry
 
1
 
R. These proteins in-
clude the 
 
a
 
-1 subunit of the L-type voltage-dependent
Ca
 
2
 
1
 
 channel dihydropyridine receptor (
 
a
 
1-DHPR) (11,
24, 27, 31, 39), FK506 binding protein, 12 kD (FKBP12)
(26), triadin (4, 8, 16, 19, 20), calsequestrin (15–17), and
calmodulin (29).
The present paper introduces a myogenic cell line (the
1B5 cell line), which expresses the major proteins known
to exist at the skeletal triad, but has been genetically engi-
neered to delete expression of Ry
 
1
 
R. The 1B5 cell line
provides a unique and powerful system with which to an-
swer questions concerning how the structure of ryanodine
receptors relate to Ca
 
2
 
1
 
 channel function and the relation-
ship among triadic proteins involved in e–c coupling by
providing a homologous expression system that lacks con-
stitutive expression of known RyR isoforms.
 
Materials and Methods
 
Creation of a Myogenic Cell Line Lacking Expression
of RyR Proteins
 
The procedures used to create a myogenic cell line lacking expression of
RyR proteins, the 
 
ry
 
1
 
r
 
2
 
/
 
ry
 
1
 
r
 
2
 
 1B5 cell line, are outlined in Fig. 1 and ex-
plained in detail below.
 
Creation of an Embryonic Stem Cell Line Possessing Two Disrupted ry
 
1
 
r
Alleles. 
 
A 9.0-kb EcoRI–Tth111I mouse genomic restriction fragment,
characterized as part of the skeletal ryanodine receptor (
 
ry
 
1
 
r
 
) was isolated
from a 129sv mouse genomic library. A neomycin cassette driven by phos-
phoglycerate kinase (PGK) promoter was inserted into exon 10 at nucle-
otide (nt) 840 of the mRNA (Fig. 2 
 
A
 
). This disrupted the transcription
reading frame and added an additional stop codon. A PGK-driven thymi-
dine kinase gene cassette was attached to the 3
 
9
 
 end as a second selection
marker to help in the efficiency of screening for homologous events. The
linearized construct was electroporated into CCS embryonic stem (ES)
cells, which were in turn grown on neomyocin antibiotic analogue (G418)-
resistant mouse embryonic fibroblast feeder cells in a medium consisting
of DME supplemented with 20% FBS, with added 2.5 mM glutamine,
penicillin, and streptomycin. The ES cells were selected in low G418 (0.4
mg/ml) for 2 d, and then G418 (0.4 mg/ml) and gangcyclovir (250 
 
m
 
M) for
8 d to improve the likelihood of eliminating clones where G418 resistance
occurred as a result of random integration (10). The resistant cell clones
were then examined for a homologous event by genomic Southern blot
analysis.
A second round of selection using high G418 (3.2 mg/ml) has been
shown to select for the rare homologous recombination of the disrupted
allele that will yield ES cells where both alleles are disrupted (30). This
technique was successfully used to produce ES cells in which both Ry
 
1
 
R
alleles were disrupted by the neomycin cassette.
 
Creation of the 1B5 ry
 
1
 
r
 
2
 
/ry
 
1
 
r
 
2
 
 Myogenic Cell Line. 
 
ES cells that were
homozygous for the disrupted 
 
ry
 
1
 
r
 
 allele were injected subcutaneously
into the hind quarters of severely compromised immunodeficient (SCID)
mice at a concentration of 2–5 
 
3
 
 10
 
6
 
 ES cells/ml in a volume of 1 ml. The
injections resulted in 
 
ry
 
1
 
r
 
2
 
/
 
ry
 
1
 
r
 
2
 
 teratocarcinomas composed of several
cell types, including skeletal muscle (5–10%). Although we were unable to
isolate myoblast cell lines using this procedure, we were able to isolate
several 
 
ry
 
1
 
r
 
2
 
/
 
ry
 
1
 
r
 
2
 
 fibroblast clonal lines that were proven to possess the
same 
 
ry
 
1
 
r
 
2
 
/
 
ry
 
1
 
r
 
2
 
 mutation of the parent ES cells by both Southern blot
and PCR analyses. Each of the fibroblast cell lines shared the following
characteristics: (
 
a
 
) they exhibited a doubling time of 18–24 h, (
 
b
 
) they
were not contact growth inhibited, and (
 
c
 
) they did not change morphol-
ogy when mitogens were withdrawn from the culture medium. These cells
have been tested for chromosome number on several occasions and have
maintained a normal complement of chromosomes after several months in
culture. Four of the 
 
ry
 
1
 
r
 
2
 
/
 
ry
 
1
 
r
 
2
 
 fibroblast lines were infected with a ret-
rovirus encoding myoD and bearing a puromycin resistance gene as a se-
lectable marker (a gift of Dr. A. Lassar, Harvard School of Medicine,
Cambridge, MA). The virus was packaged in Bosc23 cells (a gift of Dr. W.
Pear, Massachusetts Institute of Technology, Cambridge, MA), an ecotro-
pic envelope-expressing packaging cell line. The Bosc23 cells were trans-
fected with the myoD retroviral plasmid construct using CaCl
 
2
 
 shock pro-
tocol. The retroviral supernatant was harvested 48 h posttransfection by
gently removing the supernatant and filtering it through a 0.45 
 
m
 
M filter.
The retroviral supernatant was kept on ice until it was used, and the un-
used supernatant was quickly frozen and kept at 
 
2
 
80
 
8
 
C. Before infection,
the adherent 
 
ry
 
1
 
r
 
2
 
/ry
 
1
 
r
 
2
 
 fibroblasts had been plated at a density of 5 
 
3
 
10
 
5
 
 cells in growth medium per 100-mm plate.
For infection of cells with retrovirus, the standard growth medium was
replaced with 3 ml of a cocktail consisting of: (
 
a
 
) retroviral-containing su-
pernatant, (
 
b
 
) Polybrene at a final concentration of 4 
 
m
 
g/ml, and (
 
c
 
)
growth media, and allowed to incubate at 37
 
8
 
C for 3 h. Growth media (7 ml)
supplemented with bFGF (fibroblast growth factor) (25 ng/ml) was then
added to the cells. 48 h after infection, selection was begun with puromy-
cin (1 and 2 
 
m
 
g/ml) and clones were selected after 7–10 d. Puromycin-
resistant clones were subcloned in growth media consisting of DME and
20% FBS (Gibco Laboratories, Grand Island, NY). Several of the inde-
pendent subclones that were shown to express myoD by immunocy-
tochemistry, exhibited contact growth inhibition at high density in growth
medium and could be induced to differentiate into noncontractile multi-
nucleated myotubes when 5% heat-inactivated horse serum (HIHS) was
substituted for 20% FBS in DME medium (see Results). These myotubes,
but not the undifferentiated cells were shown by immunocytochemistry to
express skeletal-specific myosin heavy chain and desmin. One of the sub-
clones, the 1B5 cell line, was chosen for more complete study.
 
Southern Blot Analysis of ES Cells, Tumor Fibroblast Cells, and Con-
Figure 1. Development of the
1B5 ry1r2/ry1r2 cell line. Dia-
gram illustrating the major steps
undertaken to create a myogenic
cell line that lacks ryanodine re-
ceptor expression (the 1B5
ry1r2/ry1r2 cell line). Details are
given in Materials and Methods. 
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Myogenic Cell Line Lacking Ry
 
1
 
845
 
verted “Myoblast” Cells. 
 
The resistant CCS ES cells were expanded on gel-
atin for genomic Southern blot analysis. Analysis of the targeted 
 
ry
 
1
 
r
 
 alleles
in ES cells was performed after digesting the genomic DNA with both
EcoRI and MunI, size selecting it on a 1% agarose gel, and then transfer-
ring the DNA onto nitrocellulose paper. The DNA digest yielded a 3.0-kb
fragment in the wild-type allele and a 4.8-kb fragment in the disrupted al-
lele using a 600-bp Tth111I–EcoRI randomly labeled fragment as probe.
The Tth111I–EcoRI probe was from a region outside but adjacent to the
transfected region of homology. Results from Southern blot analysis
showed the presence of one disrupted and one wild-type allele (i.e., 
 
ry
 
1
 
r
 
1
 
/
 
ry
 
1
 
r
 
2
 
) in ES cells selected with low G418, whereas ES cells subjected to
high G418 possessed only disrupted alleles (i.e., 
 
ry
 
1
 
r
 
2/ry1r2). All of the fi-
broblast cell lines and the converted fibroblast cell lines possessed only
the disrupted alleles (i.e., ry1r2/ry1r2) derived from the ES precursor cells.
Cell Culture. All cell lines including the 1B5 cells were cultured in
growth medium consisting of DME containing 100 units/ml penicillin-G
and 100 mg/ml streptomycin sulfate, 250 nM Fungizone®, 2 mM glutamine,
and 20% FBS (vol/vol) (Gibco Laboratories) at 378C in 7% CO2. Cells
were passaged at 50–80% confluence (two to three times weekly). For ra-
tio fluorescence imaging measurements, cells were grown in 2 ml 20%
FBS-DME on 25-mm glass coverslips, and then differentiated by replacing
the growth medium with 5% HIHS (differentiation medium). The cells
were allowed to differentiate 5–7 d and then studied by immunohis-
tochemistry, Western blot analysis, radioligand receptor binding analysis,
and ratio fluorescence imaging microscopy.
Immunohistochemistry. Differentiated 1B5 cells were fixed in buffered
zinc-formalin for 15 min and washed with PBS/Tween-20 three times be-
fore blocking with 3% H2O2 for 10 min. Cells were washed again and then
blocked with 10% normal horse serum in PBS/Tween-20 for 30 min.
Blocking buffer was drained and anti-Ry1R 34C monoclonal (a gift of Dr.
J. Sutko, University of Nevada, Reno, NV) was applied at a concentration
of 1:20 in PBS for 1.5 h at 258C. Cells were washed with PBS/Tween-20
three times and then incubated with CY-3-linked goat anti–mouse IgG (1:
250) for 30 min. The cells were rinsed with Tris buffer and epifluorescence
visualized at 570 nm (excitation at 550 nm).
Microsomal Membrane Preparations. Microsomal membranes were iso-
lated from 1B5 cells that had been allowed to differentiate for 5–7 d. Cells
were scraped from 75-cm2 flasks or 100-mm plates, and then centrifuged
for 10 min at 250 g. The pellet was resuspended in buffer consisting of 250
mM sucrose, 10 mM Hepes, 1 mM EDTA, 1 mM DTT, 1 mM benzami-
dine, 1 mg/ml leupeptin, 0.7 mg/ml pepstatin A, and 0.1 mM PMSF, pH 7.4,
and then homogenized using a PowerGen 700D (Fisher Scientific, Pitts-
burgh, PA). The homogenate was centrifuged for 5 min at 250 g. The pel-
let was discarded and the 250 g supernatant was centrifuged at 10,000 g for
20 min at 48C. The 10,000 g supernatant was centrifuged at 100,000 g for 1 h
at 48C, and the microsomal pellet was resuspended at 6–15 mg/ml (23) in
10% sucrose, 20 mM Hepes, pH 7.2, frozen in liquid nitrogen, and stored
at 2808C.
For reconstitution studies in bilayer lipid membranes, differentiated
1B5 cells transiently transfected with rabbit wild-type Ry1R cDNA were
rinsed twice with ice-cold PBS, and then harvested in 137 mM NaCl, 3 mM
KCl, 8 mM Na2HPO4, 1.5 mM KH2PO4, 0.5 mM EDTA, pH 7.4. The col-
lected cells were pelleted at 600 g for 5 min. The cell pellet was then resus-
pended in ice-cold hypotonic lysis buffer (1 mM EDTA, 10 mg/ml leupep-
tin, 10 mg/ml pepstatin A, 10 mg/ml benzamidine, 10 mM Hepes, pH 7.4)
and homogenized by 10 strokes in a tight-fitting Dounce homogenizer fol-
lowed by 15 strokes after addition of an equal volume of sucrose buffer
(500 mM sucrose, 10 mM Hepes, pH 7.4). The homogenate was then run
in a Sorvall centrifuge at 10,000 g for 15 min. Microsomes were collected
by centrifugation of supernatant at 110,000 g using a Beckman Ti80 for 45
min at 48C. The resulting pellet was then resuspended in 300 mM sucrose,
10 mM Hepes-Tris, pH 7.4. The microsomal vesicles were then frozen in
N2 and stored at 2808C.
Membranes enriched in markers of junctional SR were prepared from
rabbit fast skeletal SR using the method of Saito and coworkers (37) in the
presence of protease inhibitors PMSF (100 mM) and leupeptin (10 mg/ml).
Purified heavy SR from the 38–45% interface of sucrose density gradients
was pelleted, resuspended at 3–6 mg/ml (23), frozen in liquid nitrogen,
and stored at 2808C until needed. Membranes enriched in cardiac junc-
tional SR were prepared from rabbit heart using the method of Feher and
coworkers (12). Avian junctional SR membranes were isolated from avian
pectoralis muscle according to the method of Airey and coworkers (2).
Radioligand Binding Assay. High affinity binding of [3H]ryanodine (84
Ci/mmol; New England Nuclear, Boston, MA) to membrane homoge-
nates (0.40–1 mg/ml) prepared from differentiated 1B5 (and their fibro-
blast precursor) cell lines was performed in the presence of 250 mM or 1 M
KCl, 15 mM NaCl, 20 mM Hepes, pH 7.1, 50 mM Ca21, and 1–60 nM
[3H]ryanodine. The binding reaction was initiated by addition of cell
membranes to the medium and the mixture was permitted to equilibrate
at 258C for 16 h or 378C for 3 h. Non-specific binding was assessed in the
presence of 0.5 or 1 mM unlabeled ryanodine. Under these assay condi-
tions, the KD for Ry1R in skeletal SR preparations has been found to be 1–5
nM (29). Separation of bound and free ligand was performed by rapid fil-
tration through Whatman GF/B glass fiber filters using a Brandel (Gaith-
ersburg, MD) cell harvester. Filters were washed with three volumes of 0.5
ml ice-cold wash buffer containing 20 mM Tris-HCl, 250 mM KCl, 15 mM
NaCl, 50 mM CaCl2, pH 7.1, and placed into vials with 5 ml scintillation
cocktail (Ready Safe; Beckman Instruments, Inc., Fullerton, CA). The
[3H]ryanodine remaining on the filters was quantified by liquid scintilla-
tion spectrometry.
The binding of [3H]PN200-110 to membrane-associated DHPR-a1 was
measured in 0.5 ml of buffer consisting of 5 mM KCl, 140 mM NaCl, 20 mM
Hepes, pH 7.4, and 0.1–8 nM [3H]PN200-110 (specific activity 80–87 Ci/
mmol). Cell membranes (50 mg protein per assay) were incubated for 1 h
Figure 2. Targeting construct and creation of ry1r2/ry1r2 cell
lines. (A) The targeting construct used to disrupt the ry1r gene in
CCS ES cells was composed of a 9-kb fragment of mouse 129sv
genomic DNA with an insertion vector containing a phospho-
glycerate kinase (pgk) promoter driven neomycin (Neo) cassette
inserted at nt 840 disrupting the transcription as described in Ma-
terials and Methods. A PGK-driven thymidine kinase (pgk-TK)
gene cassette was attached to the 39 end as a second selection
marker to help in the efficiency of screening for a homologous re-
combination event. N, NcoI; R, EcoRI; K, KpnI; M, MunI; and T,
Tth111I.) (B) Southern blot analysis of genomic DNA. Lane 1,
size markers obtained from bands 3–6 of BsteI-digested l DNA.
Lane 2, wild-type CCS cells that possess only the wild-type ry1r
allele. Lanes 3 and 4, CCS ES cell DNA after low (0.4 mg/ml; lane 3)
and high (3.2 mg/ml; lane 4) selection with G418. Lanes 5–7 three
independent representative fibroblast cell lines isolated from a
teratocarcinoma produced in SCID mice by injection of the ES
cells homozygous for the knockout allele. Lanes 8–10, three inde-
pendent representative myoblast cell lines that were derived by
transforming the fibroblast cell lines with a myoD-containing ret-
rovirus. The latter cell lines were selected by their proven expres-
sion of myosin and desmin, and for their ability to form multinu-
cleated “myotubes” after withdrawal of mitogens. Cell genomic
DNA was digested with EcoRI–MunI, and then hybridized with a
600-bp EcoRI–Tth111I probe. The location of the probe is shown
in (A).The Journal of Cell Biology, Volume 140, 1998 846
at 258C in the dark. Nonspecific binding was determined in the presence
of 100 mM nifedipine. Reactions were quenched by filtration as described
above and washed four times with 5 ml of wash buffer.
Western Blot Analysis. Proteins were denatured in reducing sample
buffer consisting of 48 mM NaH2PO4, 170 mM Na2HPO4, pH 7.4, 0.02%
bromophenol blue, 1% SDS (wt/vol), and 5% b-mercaptoethanol (final
concentrations). The samples were placed in boiling water for 6 min and
1–50 mg of protein was loaded onto 3–10% or 4–20% gradient SDS-
PAGE gels (21) and electrophoresed at constant voltage (200 V). The
size-separated proteins were transferred onto polyvinylidene difluoride
(PVDF) microporous membranes by electroblotter (“Mini Trans-Blot; ”
Bio-Rad Laboratories, Hercules, CA) overnight at 30 V (48C) and 1 h at
100 V. PVDF transfers were incubated with TTBS (137 mM NaCl, 20 mM
Tris-HCl, pH 7.6, 0.05% Tween-20) containing 5% (wt/vol) non-fat milk
for 1 h to block nonspecific reactions. The blots were incubated with the
selected antibody in TTBS, pH 7.6, with 1% BSA overnight at 48C. The
immunoblots were incubated with HRP-conjugated anti–mouse or anti–
rabbit IgG (Sigma Chemical Co., St. Louis, MO) for 1 h. Enhanced chemi-
luminescent techniques (Pierce Chemical Co., Piscataway, NJ) were used
to visualize the immunoblots. The antibodies used for Western analysis
were: anti-Ry1R monoclonal 34C (2), anti-Ry2R monoclonal C3-33 (22),
anti-Ry3R receptor polyclonal (14), human anti-FKBP12 monoclonal (Ver-
tex Pharmaceuticals, Cambridge, MA), anti-triadin monoclonal IIG12A8
(19), anti-calsequestrin, anti–a1-DHPR, anti–sarco(endo)plasmic reticulum
Ca21-ATPase pump (SERCA)1, and skeletal muscle–specific anti–myosin
heavy chain monoclonal antibodies (Affinity BioReagents, Neshanic, NJ).
Ratio Fluorescence Imaging. After plating in growth media for 24 h,
cells were grown on collagen-coated coverslips in differentiation medium
for 5–7 d. The differentiated cells were loaded with 5 mM fura-2AM (Mo-
lecular Probes, Inc., Eugene, OR) and 0.05% BSA (fraction V) at 378C in
5% CO2 for 20 min in loading buffer consisting of 125 mM NaCl, 5 mM
KCl, 2 mM KH2PO4, 2 mM CaCl2, 25 mM Hepes, 6 mM glucose, and 1.2 mM
MgSO4, pH 7.4. The coverslips were washed twice with 1 ml imaging
buffer (loading buffer with 250 mM sulfinpyrazone), placed in a clamp
chamber (Medical Systems, Chicago, IL), and then 1 ml of imaging buffer
placed on the cells. The cells were transferred to an inverted stage micro-
scope (Nikon Diaphot, Melville, NY) equipped with a thermostat con-
trolled plate set at 378C. Fura-2 fluorescence emission was measured from
cells visible with a 3 20 quartz objective. Fura-2 was excited alternately at
340 and 380 nm using dual automated monochrometers interfaced with a
reflective chopper and bifurcated fiber optic cable (Deltascan 1000; Photon
Technology International, Princeton, NJ). Fluorescence emission was mea-
sured at 510 nm. Data were collected from 25–50 individual cells with im-
aging equipment (intensified CCD camera; Hamamatsu Photonics,
Bridgewater, NJ) using ImageMaster software (Photon Technology Inter-
national) in Free Run mode. The data were presented as the ratio of the
emissions obtained at 340 and 380 nm (340/380).
Transient Transfection of the 1B5 Cell Line. In a six-well tissue culture
plate or 35-mm dish, 1–3 3 105 cells per dish were seeded in 2 ml of 20%
FBS DME on 12-mm glass coverslips. Cells were incubated at 378C in a
CO2 incubator until 80% confluent. Growth medium was then replaced
with differentiation medium consisting of 5% HIHS DME and allowed to
differentiate for 4 d. For each well to be transfected, solution A was com-
posed of 0.75 mg of Ry1R cDNA (pCMVRy1R) diluted into 100 ml Opti-
MEM I reduced serum medium (GIBCO BRL, Gaithersburg, MD) and
solution B was composed of 18 ml of Lipofectamine reagent (GIBCO
BRL) diluted into 100 ml Opti-MEM I reduced serum medium. For mock
transfections Ry1R cDNA (pCMVRy1R) was replaced with 1.5 mg of
b-galactosidase cDNA or all cDNA was completely removed. Solutions A
and B were prepared and mixed gently by vortex for about 5 s. Solutions
A and B were combined, mixed gently, and incubated at room tempera-
ture for 45 min to permit DNA–liposome complexes to form. Transfection
medium composed of 0.8 ml of serum-free medium was added to the tube
containing the DNA–liposome complexes and mixed gently. Each well
was rinsed once with 2 ml of serum-free medium and 1 ml of transfection
medium was then added. Transfection proceeded for 5 h at 378C in a CO2
incubator and was terminated by addition of 0.5 ml 40% FBS DME. The
transfected cells were permitted to recover for 19 h, and differentiation
medium was introduced (5% HIHS DME). The cells were monitored for
functional responses using ratio fluorescence imaging microscopy 1 d after
transfection with Ry1R cDNA. pCMVRy1R was constructed by cloning
the full-length Ry1R cDNA into the HindIII site of pCMV5. The full-
length Ry1R cDNA was obtained by cloning several smaller fragments
from a rabbit muscle cDNA library (a gift of Dr. A.R. Marks, Columbia
College of Physicians and Surgeons, New York) and assembled in the
same manner as has been previously described (4).
Electrophysiological Planar Lipid Bilayer Experiments. Planar lipid mem-
brane (BLM) reconstitution experiments were carried out with SR vesi-
cles prepared as described above from 1B5 cells transfected with Ry1R
cDNA and differentiated as described above. SR vesicles were fused into
a BLM made from a 5:3:2 mixture of phosphatidylethanolamine, phos-
phatidylserine, and phosphatidylcholine suspended in decane at 50 mg/ml.
The BLM was formed across a 250-mm hole in a polystyrene cup separat-
ing two chambers of 0.7 ml each. SR vesicles (3–15 mg protein) were
added to the cis chamber in the presence of 200 mM Ca21. The cis chamber
contained 500 mM CsCl, 20 mM Hepes, pH 7.4. The trans chamber con-
tained 100 mM CsCl, 20 mM Hepes, pH 7.4. After fusion of a single vesi-
cle, 300 mM EGTA was added to the cis chamber of the BLM to prevent
any additional fusion events. In some experiments the cis and trans cham-
bers were perfused with a solution composed of 20 mM Hepes, pH 7.4,
and 100 mM Cs1 as either the chloride or methane sulfonate salt (symmet-
rical conditions). In other experiments the cis chamber was perfused with
500 mM CsCl (asymmetrical 5:1 cis/trans conditions). A patch clamp am-
plifier (model 3900; DAGAN, Minneapolis, MN) was used to measure
currents through a single channel. The single-channel data was filtered at
2–5 kHz (Digidata 1200; Axon Instruments, Inc., Foster City, CA) and
stored on computer. Depending on the experimental conditions, calcium,
ryanodine, or ruthenium red was added to the cis chamber and stirred.
Subsequent channel gating behavior was recorded using Axotape soft-
ware (Axon Instruments, Inc.) for 1–5 min. At the end of each experiment,
10 mM ruthenium red was added to block channel function and confirm
the source of the gating currents. Single-channel data from BLM experi-
ments were analyzed using the pCLAMP software (pCLAMP version 6.0;
Axon Instruments, Inc.). Open and closed time constants were deter-
mined by least squares fit to double exponentials and steady-state channel
open probability determined.
Results and Discussion
Creation of ry1r2/ry1r2 ES cells
Fig. 2 A shows the targeting construct used to disrupt the
ry1r gene in CCS ES cells. Analysis of the targeted ry1r al-
leles was performed after digesting genomic DNA with
both EcoRI and MunI. The DNA digest yielded a 3.0-kb
fragment in the wild-type allele and a 4.8-kb fragment in
the disrupted allele using a 600-bp Tth111I–EcoRI ran-
domly labeled fragment as probe. This probe was from a
region outside but adjacent to the transfected region of
homology. Southern blot analysis indicated one disrupted
and one wild-type allele (i.e., ry1r1/ry1r2; Fig. 2 B) in the
heterozygous ES cells selected with low G418, whereas
some ES cells subjected to high G418 possessed only dis-
rupted alleles (i.e., ry1r2/ry1r2) (Fig. 2 B). Expansion of
one of these clones resulted in an ES cell line homozygous
for the disrupted allele.
ES cells injected subcutaneously into SCID mice pro-
duce teratocarcinomas in which expression of Ry1R pro-
tein is absent. Several primary fibroblast cell lines were
isolated and subcloned from one of these tumors that con-
tained the knockout mutation in both alleles. These cell
lines exhibited a doubling time of 18–24 h were not contact
growth inhibited, did not exhibit drastic morphological
change upon serum reduction, and possessed the normal
complement of chromosomes. Four of these fibroblast clones
were infected with a retrovirus containing the cDNA en-
coding myoD and a puromycin selection marker. Several
(1–2 mg/ml) puromycin-resistant subclones from each ini-
tial cell line were expanded. Upon removal of mitogens
these cell lines were examined for their ability to express
myoD and to form multinucleated myotubes that express
desmin and myosin. One of these clones (1B5 cell line)
was selected for further study. All of the tumor fibroblast
cell lines derived from these ES cells and the myoD-con-Moore et al. Myogenic Cell Line Lacking Ry1 847
verted “myoblasts” derived from the fibroblasts showed
the identical Southern pattern, thereby verifying their ori-
gin. Fig. 2 B shows Southern blot results from each of
three representative fibroblast and myoblast cell lines.
Morphology of 1B5 Cells
The typical 1B5 (ry1r2/ry1r2) cell, passaged in growth me-
dium at low density, exhibits a triangular morphology and
a single nucleus (Fig. 3). These cells expand rapidly, hav-
ing a doubling time of 18–24 h under the culture condi-
tions used. They can grow to near confluence without
spontaneously differentiating but do show growth inhibi-
tion at high density. Once mitogens are withdrawn from
the growth medium, cell division slows and the cells un-
dergo myogenic differentiation. After 5–7 d in differentia-
tion medium, most of the cells become very long and
multinucleated (Fig. 3). Immunohistochemical staining of
all of the many (.12) independent converted clonal lines
demonstrated the presence of two muscle-specific pro-
teins, skeletal muscle myosin heavy chain and desmin, in
all of the multinucleated cells (data not shown), whereas
Ry1R was not detected (Fig. 4). In consonance with immu-
nohistochemical results, the 1B5 cells have not been ob-
served to contract either spontaneously or in response to
K1 depolarization or a pharmacological agent (e.g., caffeine).
1B5 ry1r2/ry1r2 Myogenic Cells Express Major 
Elements of the Skeletal Triad
Although 1B5 cells do not express detectable levels of
Ry1R by immunohistochemical methods, it is important to
ascertain if the alternate isoforms Ry2R or Ry3R are ex-
pressed. Western blot analysis was performed with iso-
form-selective antibodies and visualized using the highly
sensitive enhanced chemiluminescence (ECL) method.
The sensitivity of this method was verified by titrating
standard SR membrane preparations (skeletal [Ry1R], car-
diac [Ry2R], or avian [Ry3R]) in the linear range of 0.1–5 mg
protein per lane. The threshold for detecting RyR protein
by laser densitometry was determined to be ,0.1 mg pro-
tein/lane for each of the RyR antibodies used in the present
study. The absence of detectable Ry1R protein in 1B5 cells
was confirmed by Western analysis of their microsomal
fraction, whereas an immunoreactive band at Mr z565,000
was observed with rabbit junctional SR (Fig. 4). Neither
Ry2R nor Ry3R immunoreactive protein was detected us-
ing antibodies selective for their respective isoforms in
preparations from the 1B5 cell line (Fig. 4). Independent
support for the absence of functional Ry1R complexes in
1B5 cell lines comes from radioligand receptor binding
studies with [3H]ryanodine. Microsomal membranes iso-
lated from 1B5 cells as well as their precursor fibroblast
line do not possess detectable specific binding in the range
of 1–30 nM [3H]ryanodine. The highly sensitive ECL
Western blot protocol fails to detect any of the known
RyR isoforms in 1B5 cells implying that either they are not
expressed or expressed at extremely low levels.
The functional importance of dihydropyridine receptors
(DHPRs) in e–c coupling has been amply demonstrated in
studies of the dysgenic mouse, which lacks expression of
Figure 3. Morphology of 1B5 myogenic cell
lines. The top panel is a representative phase-
contrast images of ry1r2/ry1r2 1B5 cells undif-
ferentiated and differentiated. Cells were cul-
tured in growth medium and photographed at a
density of 50–70% (see Materials and Methods).
The 1B5 cell line undergoes significant morpho-
logical change when cultured in 5% HIHS (dif-
ferentiation medium) for 5–7 d, exhibiting long
myotubes with multiple nuclei (arrows). The bot-
tom panel shows immunocytochemical staining
of differentiated 1B5 cells with anti-Ry1R anti-
body. 1B5 cells were permitted to differentiate
after serum withdrawal as described in Materials
and Methods. The cells were fixed and stained
with 34C monoclonal antibody selective for
Ry1R before and after transient transfection with
wild-type Ry1R cDNA. Bars: (Nondifferentiated)
40 mm; (Differentiated) 20 mm.The Journal of Cell Biology, Volume 140, 1998 848
a1-DHPR subunit and DHPR function (1). Elements of
the cytoplasmic loop between repeats 2 and 3 of DHPR-a1
interact with and modulate the function of Ry1R (25). A
homologous expression system would therefore require
expression of a1-DHPR to reconstitute the tetradic align-
ment a1-DHPR (13) and wild-type e–c coupling. Western
blot analysis of membranes isolated from differentiated 1B5
cells revealed an immunoreactive band at Mr z170,000
that coincides with a1-DHPR found in rabbit junctional
membranes (Fig. 5). The presence of a1-DHPR in 1B5 cells
was confirmed with radioligand binding studies with
[3H]PN200 (0.1–5 nM) and crude membrane homogenates
that possess a Bmax of 122 6 13 fmol/mg of specific binding
sites having a KD of 0.5 6 0.03 nM.
Interestingly these results with ry1r2/ry1r2 cell lines
parallel those recently found in neonate dyspedic and
wild-type skeletal muscle (7). Dyspedic muscle possesses a
less-developed t-system and the DHPR fails to properly
align into tetrads (38), as is normally seen in skeletal mus-
cle. L-type Ca21 inward current is significantly (z30-fold)
reduced in cultured dyspedic myotubes. However it is un-
likely that this can be accounted for by reduced density of
DHPRs since immobilization-resistant charge movement
is not significantly diminished (31). Likewise, 1B5 cells
also exhibit specific [3H]PN200-binding sites but lack de-
tectable high affinity [3H]ryanodine-binding sites (7). Fur-
ther, differentiated 1B5 myotubes possess numerous clus-
ters of large intramembrane particles of a1-DHPR which
lack tetradic arrangement. However, differentiated 1B5
cells transiently transfected with wild-type Ry1R cDNA
have restored arrays of tetrads in the 1B5 homologous ex-
pression system (35).
Several other proteins have been either proposed or
demonstrated to be important for the normal function of
Ry1R. These include (a) FKBP12, which has been shown
to stabilize the full conductance gating behavior of the
channel; (b) triadin, which has been proposed either to as-
sist in coupling the DHPR and Ry1R or to couple Ry1R
and calsequestrin; and (c) calsequestrin, which has been
proposed to receive its signal to release its bound calcium
from the Ry1R. As was found in dyspedic skeletal muscle,
all three of these proteins were detected by Western anal-
ysis of differentiated 1B5 cell membranes (Fig. 5). Immu-
nolocalization studies with antibodies directed against tri-
adin and a1 and a2 subunits of DHPR have revealed a
similar punctate pattern of labeling of these proteins in
differentiated 1B5 cells thus confirming expression and
targeting of these important triadic proteins (35). Two ad-
ditional skeletal muscle–specific proteins were also de-
tected in differentiated 1B5 cells by Western analysis:
Ca21-(Mg21) ATPase (SERCA1), the pump protein re-
sponsible for Ca21 uptake into SR, and myosin heavy
chain (Fig. 5).
Taken together, these biochemical findings reveal that
the ry1r2/ry1r2 1B5 cell line expresses the major elements
of the triad junction involved in e–c coupling with the ex-
ception of RyR proteins. The 1B5 cell line therefore pro-
vides a unique opportunity to study how RyR structure re-
lates to function within the context of a skeletal muscle
phenotype.
Transient Transfection of 1B5 Cells with Ry1R cDNA 
Restores Function
1B5 cells grown in differentiation medium were loaded
with fura-2 and examined for functional responses in an
extracellular medium that contained 10 nM free Ca21 and
responses were measured from individual cells using ratio
fluorescence imaging. 1B5 cells mock transfected with
Lipofectamine showed robust responses to ionophore
4-BrA23187 (not shown) demonstrating the integrity of
the Ca21 stores in these cells. The magnitude of this re-
sponse to ionophore was similar in sham-transfected cells
and cells transfected with Ry1R cDNA, suggesting a simi-
lar amount of Ca21 within SR stores. Sham-transfected
1B5 myotubes possessed no detectable responses to K1
(<80 mM) depolarization, ryanodine (<500 mM), or caf-
feine (<100 mM) (Fig. 6).
Differentiated 1B5 cells were transiently transfected
with Lipofectamine reagent and a plasmid containing the
wild-type Ry1R cDNA under the control of a CMV pro-
Figure 4. 1B5 cells lack de-
tectable levels of the known
RyR isoforms by Western
analysis. Western blot analy-
sis was performed as de-
scribed in Materials and
Methods and visualized by
the ECL method. Ry1R pro-
tein is not detected in 1B5
cells. 1B5 cells do not possess
detectable levels of Ry2R or Ry3R immunoreactive protein. The
lanes were loaded as follows: Avian protein (avi; 10 mg), rabbit
cardiac (crd; 15 mg), rabbit skeletal junctional sarcoplasmic retic-
ulum (jsr; 5 mg), and 1B5 protein (1B5; 50 mg). Gels were 3–10%
SDS–polyacrylamide. These experiments were repeated at least
twice with each primary antibody. ECL exposure time of up to 24 h
showed no detectable levels of the known RyR isoforms.
Figure 5. 1B5 cells express key triadic proteins. Western blots
were developed by ECL technique for the length of time indi-
cated as follows: a1-DHPR, 30 s; FKBP12, 1 min; triadin, 1 min
jsr and 10 min 1B5; and calsequestrin, 1 min jsr and 10 min 1B5.
Two additional skeletal muscle proteins detected in 1B5 cells are
SERCA1 and skeletal myosin heavy chain (ECL exposure time
of 5 and 1 min, respectively). The lanes were loaded as follows:
rabbit skeletal junctional sarcoplasmic reticulum (jsr) 5 mg except
for myosin and SERCA1; 1 mg) and 1B5 protein (50 mg). Gels
were 3–10% or 4–20% (for FKBP12) SDS–polyacrylamide. This
experiment was repeated at least twice with each primary anti-
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moter as described in Materials and Methods. The trans-
fection protocol results in efficient reconstitution of de-
tectable Ry1R protein in 1B5 cells, and immunofluorescence
reveals punctate rather than diffuse labeling (Fig. 3). The
functional responses of fura-2–loaded 1B5 cells trans-
fected with wild-type Ry1R cDNA were analyzed using ra-
tio fluorescence imaging microscopy. Transfection of 1B5
myotubes with the full-length Ry1R cDNA restored re-
sponses to K1 (40 mM) depolarization that was indepen-
dent of extracellular Ca21 (Fig. 6), suggesting a restoration
of skeletal-type e–c coupling in the 1B5 cell. In this re-
spect, 1B5 cells expressing functional Ry1R protein and
skeletal-type e–c coupling would be expected to regain an
ordered tetradic array of a1-DHPR subunits. Initial re-
sults obtained from freeze fractures performed with 1B5
cells transfected with Ry1R cDNA has confirmed this hy-
pothesis (34). The efficiency of recovering depolarization
induced Ca21 release using transient transfection with Li-
pofectamine ranged from 20 to 50% within any given field
in 14 different experiments. Transfection of 1B5 cells also
restored responses to ryanodine in 10 out of 10 indepen-
dent transfections, with at least six coverslips examined
per transfection. The typical response to ryanodine was
also independent of extracellular Ca21, although the rate
of change in intracellular Ca21 was significantly slower
than the response seen with K1 (Fig. 6). Caffeine as high
as 100 mM failed to elicit a response in sham-transfected
1B5 cells whereas transfection with Ry1R cDNA resulted
in the anticipated response. Myotube contractions were
observed during experiments using ryanodine and caffeine
on 1B5 cells transiently transfected with Ry1R cDNA
(data not shown).
Additional evidence that Ry1R protein was targeted to
SR membranes of 1B5 cells transiently transfected with
Ry1R cDNA was obtained from imaging studies per-
formed in Ca21 replete medium and 1 mM thapsigargin.
Thapsigargin, a known selective cell permeant blocker of
SERCA pumps was used to assess the nature of the ryano-
dine-sensitive store. Ryanodine (200 mM) produced a
transient elevation in intracellular Ca21 which was similar
to that seen in Ca21-free medium (Fig. 7 A). Subsequent
addition of thapsigargin revealed that the SR store reaccu-
mulated Ca21. These results are consistent with the known
sequential effects of micromolar ryanodine on SR Ca21
channel function, first activating and then inhibiting (33).
Importantly, if thapsigargin is introduced into the cell me-
dium first to completely deplete the microsomal stores,
subsequent addition of ryanodine fails to produce a de-
tectable response (Fig. 7 B). These results provide inde-
pendent verification that Ry1R protein is targeted cor-
rectly to the SR membrane.
Reconstitution of Wild-Type Single Channels from 1B5 
Cells Expressing Ry1R cDNA
Several (.30) attempts to reconstitute ryanodine-sensitive
Ca21 channels from nontransfected 1B5 microsomes into
planar bilayer membranes have failed to produce the
large, ryanodine-sensitive current fluctuations that are
consistent with Ry1R. SR membranes prepared from 1B5
cells transfected with wild-type rabbit Ry1R cDNA pro-
duce successful channel fusions with gating transitions;
Figure 6. Transient transfection of 1B5 cells with Ry1R cDNA
restores responses to K1 depolarization, ryanodine, and caffeine.
Ratio fluorescence imaging of individual differentiated myotubes
was performed as described in Materials and Methods. All exper-
iments were performed in the presence of an extracellular me-
dium buffered to 10 nM free Ca21 to eliminate Ca21 influx. The
top panel shows a typical experiment demonstrating lack of re-
sponse to K1 depolarization (40 mM) in mock-transfected 1B5
cells (of 48 cells examined, 0 responded), and restoration of the
response after transient transfection with wild-type Ry1R cDNA
(of 163 cells examined, 50 responded). The middle panel shows a
typical result with ryanodine (200 mM) on differentiated 1B5 cells
before and after transfection with wild-type Ry1R cDNA. In n 5
260 total measurements, no Ry1R null cell was ever found to re-
spond to ryanodine. After transfection using the wild-type Ry1R
cDNA, 106 1B5 cells responded to 200 mM ryanodine out of 111
cells examined in calcium-free media. The bottom panel shows a
typical response to 50 mM caffeine from mock transfected (of 34
cells examined, 0 responded) and Ry1R cDNA–transfected (of 82
cells examined, 51 responded) 1B5 cells. In 109 total measure-
ments, no Ry1R null cell was ever found to respond to caffeine
(10–100 mM).
Figure 7. Targeting of Ry1R
protein to SR membranes of
1B5 cells transiently trans-
fected with Ry1R cDNA. Ra-
tio fluorescence imaging of
individual differentiated myo-
tubes in 2 mM extracellular
Ca21 was performed as de-
scribed in Materials and
Methods. (A) Typical experi-
ment demonstrating the re-
sponse to ryanodine (200 mM)
in 1B5 myotubes transiently
transfected with wild-type
Ry1R cDNA followed by the
addition of thapsigargin (1 mM)
(n  5 63). (B) Typical re-
sponse of 1B5 cells transiently
transfected with wild-type
Ry1R cDNA to thapsigargin (1 mM) followed by ryanodine (200
mM) (n 5 61). The Journal of Cell Biology, Volume 140, 1998 850
these gating transitions are predominately of the full-con-
ductance type, characteristic of those seen with reconsti-
tuted channels from rabbit junctional SR (Fig. 8 A). The
current/voltage relationship from channels isolated from
1B5 cells yielded a linear current/voltage relationship from
240 to 140 mV that are indistinguishable from channels
reconstituted from rabbit SR (Fig. 8 B). Further, the uni-
tary conductance of n 5 8 expressed channels averaged
451 6 77 pS, which is not statistically different from that of
channels obtained from native rabbit skeletal muscle SR
(6). Channel fluctuations from the recombinant channels
are very rapid with t1 and t2 averaging 0.6 and 2.9 ms, as
expected for a wild-type channel. The addition of 4 mM ry-
anodine to the cis chamber produced a long-lived subcon-
ductance z50% of the native channel, whereas 10 mM ru-
thenium red completely blocked the Cs1 current (Fig. 8 C).
The steady-state open probability was highly dependent
on the concentration of Ca21 in the cis chamber (not shown)
with the open probability (Po) ranging from 0.1 to 0.4 at
50 mM Ca21 cis (n 5 8 channels).
Conclusion
The 1B5 myogenic cell line provides a truly homologous
expression system to investigate the relationships between
structure and function of ryanodine receptors. Several
benefits are realized from the 1B5 cell model over other
cell lines used to express ryanodine receptors. First, key
triadic proteins normally present at the skeletal muscle
triad are also present in 1B5 cells including a1-DHPR,
FKBP12, triadin, calsequestrin, and SERCA1. Second, by
virtue of being a stable line, the 1B5 cells permit efficient
transient transfection of cDNAs encoding for RyR pro-
teins. Transient transfection of 1B5 cells with pCMVRy1R
using Lipofectamine reagent reveals that Ry1R function
can be efficiently restored at the level of the cell (Figs. 6
and 7) and single channel (Fig. 8). Further, the 1B5 line
will permit creation of subclones permanently expressing
RyR proteins, which possess defined mutations that should
prove invaluable for structure/function studies at both the
cellular and single channel levels. This approach should
circumvent all of the major problems currently confront-
ing transient transfection studies in heterologous systems.
Finally, the biochemical and functional studies presented
here indicate that 1B5 cells provide a truly null background
for ryanodine receptors, which will permit unambiguous
interpretations of results from structure function studies of
this protein.
We gratefully acknowledge Drs. E. Buck and W. Feng (University of Cal-
ifornia, Davis, CA) for assistance with BLM experiments. We also thank
T. Meloy, J. Abenojar, T. Taras, E. Kuehnis, and W. Brackney for their
technical assistance.
This work was supported by a Public Health Service grant AR 413140
(P.D. Allen and I.N. Pessah), Muscular Dystrophy Association (P.D.
Allen), American Heart Association, California Affiliate (I.N. Pessah),
and National Institutes of Health Training Grant in Cardiovascular and
Neurophysiology HL07682 (R.A. Moore), and American Heart Associa-
tion, California Affiliate 97-403 (R.A. Moore).
Received for publication 15 September 1997 and in revised form 17 De-
cember 1997.
References
1. Adams, B.A., T. Tanabe, A. Mikami, S. Numa, and K.G. Beam. 1990. In-
tramembrane charge movement restored in dysgenic skeletal muscle by
injection of dihydropyridine receptor cDNAs. Nature. 346:569–572.
2. Airey, J.A., C.F. Beck, K. Murakami, S.J. Tanksley, T.J. Deerinck, M.H.
Ellisman, and J.L. Sutko. 1990. Identification and localization of two
triad junctional foot protein isoforms in mature avian fast twitch skeletal
muscle [published erratum appears in J. Biol. Chem. 1990. 265:22057.] J.
Biol. Chem. 265:14187–14194.
3. Bhat, M.B., J. Zhao, S. Hayek, E.C. Freeman, H. Takeshima, and J. Ma.
Figure 8. Reconstitution of single channels from 1B5 cells ex-
pressing wild-type rabbit skeletal Ry1R. (A) Single channel
records (450 ms/trace) obtained from 1B5 cell SR expressing
Ry1R. Channel currents were measured with 50 mM Ca21 in the
cis chamber and symmetric 100 mM Cs21. (B) Current–voltage
relationship from a single expressed ryanodine receptor and a
control ryanodine receptor. (C) The effect of 4 mM ryanodine
and 10 mM ruthenium red on expressed ryanodine receptor acti-
vated with 100 mM Ca21 in the cis chamber at 130 mV in asym-
metric Cs21 (5:1). Similar gating behavior was obtained from n 5
8 channels (see text for details).Moore et al. Myogenic Cell Line Lacking Ry1 851
1997. Deletion of amino acids 1641-2437 from the foot region of skeletal
muscle ryanodine receptor alters the conduction properties of the Ca re-
lease channel. Biophys. J. 73:1320–1328.
4. Brandt, N.R., A.H. Caswell, J.P. Brunschwig, J.J. Kang, B. Antoniu, and N.
Ikemoto. Effects of anti-triadin antibody on Ca21 release from sarco-
plasmic reticulum. FEBS (Fed. Eur. Biochem. Soc.) Lett. 299:57–59.
5. Brillantes, A.B., K. Ondrias, A. Scott, E. Kobrinsky, E. Ondriasova, M.C.
Moschella, T. Jayaraman, M. Landers, B.E. Ehrlich, and A.R. Marks.
1994. Stabilization of calcium release channel (ryanodine receptor) func-
tion by FK506-binding protein. Cell. 77:513–523.
6. Buck, E., I. Zimanyi, J.J. Abramson, and I.N. Pessah. 1992. Ryanodine sta-
bilizes multiple conformational states of the skeletal muscle calcium re-
lease channel. J. Biol. Chem. 267:23560–23567.
7. Buck, E.D., H.T. Nguyen, I.N. Pessah, and P.D. Allen. 1997. Dyspedic
mouse skeletal muscle express major elements of the triadin junction but
lacks detectable ryanodine receptor protein and function. J. Biol. Chem.
272:7360–7367.
8. Caswell, A.H., N.R. Brandt, J.P. Brunschwig, and S. Purkerson. 1991. Lo-
calization and partial characterization of the oligomeric disulfide-linked
molecular weight 95,000 protein (triadin) which binds the ryanodine and
dihydropyridine receptors in skeletal muscle triadic vesicles. Biochemis-
try. 30:7507–7513.
9. Chen, S.R., D.M. Vaughan, J.A. Airey, R. Coronado, and D.H. MacLen-
nan. 1993. Functional expression of cDNA encoding the Ca21 release
channel (ryanodine receptor) of rabbit skeletal muscle sarcoplasmic
reticulum in COS-1 cells. Biochemistry. 32:3743–3753.
10. Doetschman, T.C., H. Eistetter, M. Katz, W. Schmidt, and R. Kemler. 1985.
The in vitro development of blastocyst-derived embryonic stem cell lines;
formation of visceral yolk sac, blood islands and myocardium. J. Em-
bryol. Exp. Morph. 82:27–45.
11. el-Hayek, R., B. Antoniu, J. Wang, S.L. Hamilton, and N. Ikemoto. 1995.
Identification of calcium release-triggering and blocking regions of the
II-III loop of the skeletal muscle dihydropyridine receptor. J. Biol. Chem.
270:22116–22118.
12. Feher, J.J., and M.D. Davis. 1991. Isolation of rat cardiac sarcoplasmic
reticulum with improved Ca21 uptake and ryanodine binding. J. Mol.
Cell. Cardiol. 23:249–258.
13. Franzini-Armstrong, C., M. Pincon-Raymond, and F. Rieger. 1991. Muscle
fibers from dysgenic mouse in vivo lack a surface component of periph-
eral couplings. Dev. Biol. 146:364–736.
14. Giannini, G., A. Conti, S. Mammarella, M. Scrobogna, and V. Sorrentino.
1995. The ryanodine receptor/calcium channel genes are widely and dif-
ferentially expressed in murine brain and peripheral tissues. J. Cell Biol.
128:893–904.
15. Gilchrist, J.S., A.N. Belcastro, and S. Katz. 1992. Intraluminal Ca21 depen-
dence of Ca21 and ryanodine-mediated regulation of skeletal muscle sar-
coplasmic reticulum Ca21 release. J. Biol. Chem. 267:20850–20856.
16. Guo, W., and K.P. Campbell. 1995. Association of triadin with the ryano-
dine receptor and calsequestrin in the lumen of the sarcoplasmic reticu-
lum. J. Biol. Chem. 270:9027–9030.
17. Ikemoto, N., B. Antoniu, J.J. Kang, L.G. Meszaros, and M. Ronjat. 1991.
Intravesicular calcium transient during calcium release from sarcoplas-
mic reticulum. Biochemistry. 30:5230–5237.
18. Inesi, G., and Y. Sagara. 1994. Specific inhibitors of intracellular Ca21
transport ATPase. J. Membr. Biol. 141:1–6.
19. Knudson, C.M., K.K. Stang, A.O. Jorgensen, and K.P. Campbell. 1993.
Biochemical characterization of ultrastructural localization of a major
junctional sarcoplasmic reticulum glycoprotein (triadin). J. Biol. Chem.
268:12637–12645.
20. Knudson, C.M., K.K. Stang, C.R. Moomaw, C.A. Slaughter, and K.P.
Campbell. 1993. Primary structure and topological analysis of a skeletal
muscle-specific junctional sarcoplasmic reticulum glycoprotein (triadin).
J. Biol. Chem. 268:12646–12654.
21. Laemmli, U.K. 1970. Cleavage of structural proteins during the assembly of
the head of bacteriophage T4. Nature. 227:680–685.
22. Lai, F.A., M. Dent, C. Wickenden, L. Xu, G. Kumari, M. Misra, H.B. Lee,
M. Sar, and G. Meissner. 1992. Expression of cardiac Ca21-release chan-
nel isoform in mammalian brain. Biochem. J. 288:553–564.
23. Lowry, O.H., N.J. Rosenbrough, A.L. Farr, and R.J. Randall. 1951. Protein
measurement with folin phenol reagent. J. Biol. Chem. 193:265–275.
24. Lu, X., L. Xu, and G. Meissner. 1994. Activation of the skeletal muscle cal-
cium release channel by a cytoplasmic loop of the dihydropyridine recep-
tor. J. Biol. Chem. 269:6511–6516.
25. Lu, X., L. Xu, and G. Meissner. 1995. Phosphorylation of dihydropyridine
receptor II-III loop peptide regulates skeletal muscle calcium release
channel function. Evidence for an essential role of the b-OH group of
Ser687. J. Biol. Chem. 270:18459–18464.
26. Marks, A., S. Fleisher, B. Nadal-Ginard, and P. Tempst. 1990. Surface to-
pography analysis of the ryanodine receptor/junctional channel complex
based on proteolysis sensitivity mapping. J. Biol. Chem. 265:13143–13149.
27. Marty, I., M. Robert, M. Villaz, W.A. Catterall, and M. Ronjat. 1994. Bio-
chemical evidence for a complex involving dihydropyridine receptor and
ryanodine receptor in triad junction of skeletal muscle. Proc. Natl. Acad.
Sci. USA. 91:2270–2274.
28. McPherson, P.S., and K.P. Campbell. 1993. The ryanodine receptor/Ca21
release channel. J. Biol. Chem. 268:13765–13768.
29. Meissner, G. 1994. Annu. Rev. Physiol. 56:485–508.
30. Mortensen, R.M., D.A. Conner, S. Chao, A.A. Geisterfer-Lowrance, and
J.G. Seidman. 1992. production of homozygous mutant ES cells with a
single targeting construct. Mol. Cell. Biol. 12:2391–2395.
31. Nakai, J., R.T. Dirksen, H.T. Nguyen, I.N. Pessah, K.G. Beam, and P.D.
Allen. 1996. Enhanced dihydropyridine receptor channel activity in the
presence of ryanodine receptor. Nature. 380:72–75.
32. Penner, R., E. Neher, H. Takeshima, S. Nishimura, and S. Numa. 1989.
Functional expression of the calcium release channel from skeletal mus-
cle ryanodiine receptor cDNA. FEBS (Fed. Eur. Biochem. Soc.) Lett.
259:217–221.
33. Pessah, I.N., and I. Zimanyi. 1991. Characterization of multiple [3H]ryano-
dine binding sites on the Ca21 release channel of sarcoplasmic reticulum
from skelet al and cardiac muscle: evidence for a sequential mechanism
in ryanodine action. Mol. Pharmacol. 39:679–689.
34. Philips, M.S., J. Fujii, V.K. Khanna, S. DeLeon, K. Yokobata, P.J. de Jong,
and D.H. MacLennan. 1996. The structure organization of the human
skeletal muscle ryanodine (RyR1) gene. Genomics. 34:24–41.
35. Protasi, F., C. Franzini-Armstrong, and P.D. Allen. 1998. Role of ryano-
dine receptors in the assembly of calcium release units in skeletal muscle.
J. Cell. Biol. 140:831–842.
36. Rios, E., J.J. Ma, and A. Gonzalez. 1991. The mechanical hypothesis of ex-
citation-contraction (EC) coupling in skeletal muscle. J. Muscle Res. Cell.
Motil. 12:127–135.
37. Saito, A., S. Seiler, A. Chu, and S. Fleischer. 1984. Preparation and mor-
phology of sarcoplasmic reticulum terminal cisternae from rabbit skeletal
muscle. J. Cell Biol. 99:875–885.
38. Takekura, H., M. Nishi, T. Noda, H. Takeshima, and C. Franzini-Arm-
strong. 1995. Abnormal junctions between surface membrane and sarco-
plasmic reticulum in skeletal muscle with a mutation targeted to the ryan-
odine receptor. Proc. Natl. Acad. Sci. USA. 92:3381–3385.
39. Tanabe, T., K.G. Beam, B.A. Adams, T. Niidome, and S. Numa. 1990. Re-
gions of the skeletal muscle dihydropyridine receptor critical for excita-
tion-contraction coupling. Nature. 346:567–569.